Fig. 3From: Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transitioneIF5A2 overexpression reduced doxorubicin sensitivity. eIF5A2 plasmids were transfected into LOVO (a), SW480 (b), HCT116 (c) and HT29 (d) cells. 48 h after transfection, CCK-8 assay was performed to measure cell viability in the presence of doxorubicinBack to article page